Moreover, the detection of CD47highand/orPD-L1high CTCs numerically prevailed in de novo metastatic disease (Figure 1D), where all CD47+/PD-L1+ CTCs presented high expression levels of both markers. This evidence concerns the gene CD274 and metastatic neoplasm.